搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Silicibacter sp. 50S ribosomal protein L2 (rplB) CSB-YP625262SAAR
CSB-EP625262SAAR
CSB-BP625262SAAR
CSB-MP625262SAAR
CSB-EP625262SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. 30S ribosomal protein S7 (rpsG) CSB-YP625263SAAR
CSB-EP625263SAAR
CSB-BP625263SAAR
CSB-MP625263SAAR
CSB-EP625263SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. 50S ribosomal protein L11 (rplK) CSB-YP625264SAAR
CSB-EP625264SAAR
CSB-BP625264SAAR
CSB-MP625264SAAR
CSB-EP625264SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP625265SAAR
CSB-EP625265SAAR
CSB-BP625265SAAR
CSB-MP625265SAAR
CSB-EP625265SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Bifunctional purine biosynthesis protein PurH (purH), partial CSB-YP625266SAAR
CSB-EP625266SAAR
CSB-BP625266SAAR
CSB-MP625266SAAR
CSB-EP625266SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Leucine--tRNA ligase (leuS), partial CSB-YP625267SAAR
CSB-EP625267SAAR
CSB-BP625267SAAR
CSB-MP625267SAAR
CSB-EP625267SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Maf-like protein TM1040_3556 (TM1040_3556) CSB-YP625268SAAR
CSB-EP625268SAAR
CSB-BP625268SAAR
CSB-MP625268SAAR
CSB-EP625268SAAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Silicibacter sp. Glycerol-3-phosphate acyltransferase (plsY), partial CSB-YP625269SAAR1
CSB-EP625269SAAR1
CSB-BP625269SAAR1
CSB-MP625269SAAR1
CSB-EP625269SAAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis UPF0314 protein Sala_3154 (Sala_3154), partial CSB-YP625270SAAS1
CSB-EP625270SAAS1
CSB-BP625270SAAS1
CSB-MP625270SAAS1
CSB-EP625270SAAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 6,7-dimethyl-8-ribityllumazine synthase (ribH) CSB-YP625271SAAS
CSB-EP625271SAAS
CSB-BP625271SAAS
CSB-MP625271SAAS
CSB-EP625271SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis tRNA modification GTPase MnmE (mnmE) CSB-YP625272SAAS
CSB-EP625272SAAS
CSB-BP625272SAAS
CSB-MP625272SAAS
CSB-EP625272SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (gpmA) CSB-YP625273SAAS
CSB-EP625273SAAS
CSB-BP625273SAAS
CSB-MP625273SAAS
CSB-EP625273SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L2 (rplB) CSB-YP625274SAAS
CSB-EP625274SAAS
CSB-BP625274SAAS
CSB-MP625274SAAS
CSB-EP625274SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L5 (rplE) CSB-YP625275SAAS
CSB-EP625275SAAS
CSB-BP625275SAAS
CSB-MP625275SAAS
CSB-EP625275SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis 50S ribosomal protein L30 (rpmD) CSB-YP625276SAAS
CSB-EP625276SAAS
CSB-BP625276SAAS
CSB-MP625276SAAS
CSB-EP625276SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Diaminopimelate epimerase (dapF) CSB-YP625277SAAS
CSB-EP625277SAAS
CSB-BP625277SAAS
CSB-MP625277SAAS
CSB-EP625277SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis UPF0178 protein Sala_2376 (Sala_2376) CSB-YP625278SAAS
CSB-EP625278SAAS
CSB-BP625278SAAS
CSB-MP625278SAAS
CSB-EP625278SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Malate dehydrogenase (mdh) CSB-YP625279SAAS
CSB-EP625279SAAS
CSB-BP625279SAAS
CSB-MP625279SAAS
CSB-EP625279SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Queuine tRNA-ribosyltransferase (tgt) CSB-YP625280SAAS
CSB-EP625280SAAS
CSB-BP625280SAAS
CSB-MP625280SAAS
CSB-EP625280SAAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingopyxis alaskensis Protein CrcB homolog (crcB), partial CSB-YP625281SAAS1
CSB-EP625281SAAS1
CSB-BP625281SAAS1
CSB-MP625281SAAS1
CSB-EP625281SAAS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>